BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Zhou J, Qiu J, Huang Z, Wang W, Wu P, Feng A. Berberine reduces gut-vascular barrier permeability via modulation of ApoM/S1P pathway in a model of polymicrobial sepsis. Life Sci 2020;261:118460. [PMID: 32961234 DOI: 10.1016/j.lfs.2020.118460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Xu D, Chen Y, Yue S, Fu R, Huang L, Tang Y. Traditional Chinese Medicine: A promising strategy to regulate inflammation, intestinal disorders and impaired immune function due to sepsis. Front Pharmacol 2022;13:952938. [DOI: 10.3389/fphar.2022.952938] [Reference Citation Analysis]
2 Wang Y, Zhang D, Li C, Wu X, He C, Zhu X, Zhao H, Mu L. Toll-like receptor 4-mediated endoplasmic reticulum stress induces intestinal paneth cell damage in mice following CLP-induced sepsis. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-19614-6] [Reference Citation Analysis]
3 Carloni S, Rescigno M. Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers. Semin Immunopathol 2022. [PMID: 35861857 DOI: 10.1007/s00281-022-00955-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Izadparast F, Riahi-zajani B, Yarmohammadi F, Hayes AW, Karimi G. Protective effect of berberine against LPS-induced injury in the intestine: a review. Cell Cycle. [DOI: 10.1080/15384101.2022.2100682] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang YF, Li JW, Wang DP, Jin K, Hui JJ, Xu HY. Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function. Drug Des Devel Ther 2022;16:1697-711. [PMID: 35693534 DOI: 10.2147/DDDT.S360348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ai X, Yu P, Peng L, Luo L, Liu J, Li S, Lai X, Luan F, Meng X. Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases. Front Pharmacol 2021;12:762654. [PMID: 35370628 DOI: 10.3389/fphar.2021.762654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zou G, Zhu Q, Ren B, Guo Q, Wu Y, He J, Wu Y, Luo Z. HDL-Associated Lipoproteins: Potential Prognostic Biomarkers for Gram-Negative Sepsis. JIR 2022;Volume 15:1117-31. [DOI: 10.2147/jir.s350737] [Reference Citation Analysis]
8 Zhang YN, Chang ZN, Liu ZM, Wen SH, Zhan YQ, Lai HJ, Zhang HF, Guo Y, Zhang XY. Dexmedetomidine Alleviates Gut-Vascular Barrier Damage and Distant Hepatic Injury Following Intestinal Ischemia/Reperfusion Injury in Mice. Anesth Analg 2021. [PMID: 34889823 DOI: 10.1213/ANE.0000000000005810] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Carloni S, Bertocchi A, Mancinelli S, Bellini M, Erreni M, Borreca A, Braga D, Giugliano S, Mozzarelli AM, Manganaro D, Fernandez Perez D, Colombo F, Di Sabatino A, Pasini D, Penna G, Matteoli M, Lodato S, Rescigno M. Identification of a choroid plexus vascular barrier closing during intestinal inflammation. Science 2021;374:439-48. [PMID: 34672740 DOI: 10.1126/science.abc6108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
10 Grander C, Grabherr F, Spadoni I, Enrich B, Oberhuber G, Rescigno M, Tilg H. The role of gut vascular barrier in experimental alcoholic liver disease and A. muciniphila supplementation. Gut Microbes 2020;12:1851986. [PMID: 33382359 DOI: 10.1080/19490976.2020.1851986] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]